These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 16112970)
41. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome. Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499 [TBL] [Abstract][Full Text] [Related]
42. Head-to-head comparison of B-type natriuretic peptide (BNP) and NT-proBNP in daily clinical practice. Mair J; Gerda F; Renate H; Ulmer H; Andrea G; Pachinger O Int J Cardiol; 2008 Feb; 124(2):244-6. PubMed ID: 17360054 [TBL] [Abstract][Full Text] [Related]
43. Updating the role of natriuretic peptide levels in cardiovascular disease. Gopal DJ; Iqbal MN; Maisel A Postgrad Med; 2011 Nov; 123(6):102-13. PubMed ID: 22104459 [TBL] [Abstract][Full Text] [Related]
44. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes. Coppola G; Corrado E; Mulè MC; Augugliaro S; Cucchiara A; Novo G; Amoroso G; Assennato P; Hoffmann E; Vitale F; Novo S Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249 [TBL] [Abstract][Full Text] [Related]
45. Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure. Baggish AL; van Kimmenade RR; Januzzi JL Am J Cardiol; 2008 Feb; 101(3A):49-55. PubMed ID: 18243859 [TBL] [Abstract][Full Text] [Related]
46. Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (Nt-proBNP) in the elderly. Alehagen U; Goetze JP; Dahlström U Clin Chim Acta; 2007 Jul; 382(1-2):8-14. PubMed ID: 17433809 [TBL] [Abstract][Full Text] [Related]
47. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP. Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Van Veldhuisen DJ Europace; 2006 Jul; 8(7):482-7. PubMed ID: 16798760 [TBL] [Abstract][Full Text] [Related]
48. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients. Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210 [TBL] [Abstract][Full Text] [Related]
49. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure. Perna ER; Macin SM; Cimbaro Canella JP; Szyszko A; Franciosi V; Vargas Morales W; Bayol AP; Kriskovich JO; Medina F; Gonzalez Arjol B; Brizuela M J Heart Lung Transplant; 2006 Oct; 25(10):1230-40. PubMed ID: 17045936 [TBL] [Abstract][Full Text] [Related]
51. Amino-terminal pro-brain natriuretic Peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction? van Kimmenade RR; Januzzi JL; Baggish AL; Lainchbury JG; Bayes-Genis A; Richards AM; Pinto YM J Am Coll Cardiol; 2006 Oct; 48(8):1621-7. PubMed ID: 17045898 [TBL] [Abstract][Full Text] [Related]
52. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure. Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415 [TBL] [Abstract][Full Text] [Related]
53. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Felker GM; Hasselblad V; Hernandez AF; O'Connor CM Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866 [TBL] [Abstract][Full Text] [Related]
54. Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure. van Kimmenade RR; Pinto YM; Bayes-Genis A; Lainchbury JG; Richards AM; Januzzi JL Am J Cardiol; 2006 Aug; 98(3):386-90. PubMed ID: 16860029 [TBL] [Abstract][Full Text] [Related]
55. BNP or NTproBNP? A clinician's perspective. Steiner J; Guglin M Int J Cardiol; 2008 Sep; 129(1):5-14. PubMed ID: 18378336 [TBL] [Abstract][Full Text] [Related]
56. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center. Amir O; Paz H; Ammar R; Yaniv N; Schliamser JE; Lewis BS Isr Med Assoc J; 2008 Feb; 10(2):109-12. PubMed ID: 18432021 [TBL] [Abstract][Full Text] [Related]
57. [Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease]. Pfister R; Tan D; Thekkanal J; Erdmann E; Schneider CA Dtsch Med Wochenschr; 2008 Mar; 133(12):564-9. PubMed ID: 18335382 [TBL] [Abstract][Full Text] [Related]
58. [Brain natriuretic Peptide. Diagnostic and prognostic value in chronic heart failure]. Krüger S; Hoffmann R; Graf J; Janssens U; Hanrath P Med Klin (Munich); 2003 Oct; 98(10):562-7. PubMed ID: 14586510 [TBL] [Abstract][Full Text] [Related]
59. Guiding and monitoring of heart failure therapy with NT-ProBNP: concepts and clinical studies. Richards AM; Troughton R; Lainchbury J; Doughty R; Wright S J Card Fail; 2005 Jun; 11(5 Suppl):S34-7. PubMed ID: 15948098 [TBL] [Abstract][Full Text] [Related]